News

An analysis of EHR data recorded from 2018-2022 within Duke University Medical Center-affiliated diabetes care centers suggests the increased rate of new-onset type 1 and type 2 diabetes observed during the first year of the pandemic persisted through 2022.

The AI chatbot, ChatGPT-4, responded correctly to 84% of multiple-choice practice questions on the OphthoQuestions trial, compared to 58% in February 2023.

Investigators noted both direct and indirect standardization are valid methods for comparing mortality rates. However, direct standardization is particularly useful when assessing disease burdens across multiple groups.

The main pharmacokinetic parameters were comparable between the tocilizumab reference and the biosimilar cohorts.

The American Heart Association has released a new scientific statement on the current science on the health effects of e-cigarette use and calls for more studies regarding their long-term impact.

Sleep quality and the absence of sleep apnea may play a crucial role in preserving cognitive function over time, emphasizing the significance of addressing sleep disturbances for overall brain health.

A retrospective analysis shows the highly deadly condition has increased 7-fold among US women in the last 2 decades.

In his interview, Dr. Amin discusses his views on the FDA’s recent approval of ritlecitinib for the treatment of adolescent patients with alopecia areata.

Reaffirming their 2016 recommendation, the USPSTF concluded current evidence was insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents in their latest recommendation statement.

For this segment of her interview, Dr. Mellerio further discussed the contents of her talk on new treatment options for epidermolysis bullosa, highlighting DEB and EB simplex.

An analysis of patient data from the greater Houston area suggests women were less likely to be routed to a comprehensive stroke center than their male counterparts, despite a greater symptom severity and comparable distance to the centers.

Real-world evidence suggests the rapid reduction of HbA1c is not associated with early worsening in subjects with T2D with mild or moderate nonproliferative DR.

The findings underscore the importance of considering both the severity of BPD features and changes in depressive symptoms when assessing risk of suicide.

Women with type 1 diabetes experience a three times greater risk of sexual dysfunction than women without diabetes.

The study provides valuable insights into the medication behavior of patients receiving SSRIs.

In the latest Lungcast, a nationally-leading researcher and long COVID patient discusses what's known and unknown about the chronic viral syndrome.

Announced on July 17, 30-month data from the ATTRibute-CM trial provide the most comprehensive insight yet into the long-term effects of acoramidis use in patients with transthyretin amyloid cardiomyopathy.

In this interview segment, Dr. Mellerio spoke about the contents of her presentation titled ‘New Treatment Approaches for Epidermolysis Bullosa.’

A randomized trial of patients with kidney failure undergoing hemodialysis is underlining the importance of physical activity among this patient population.

This new data indicates that while it is not a physically limiting disease, alopecia areata can substantially affect patients’ lives on an individual and national level.

Over 3 years, global health threats and national headlines have spurred medical schools to better address social and community-based determinants of health. What comes next?

"These findings may be used to change attitudes toward mental health disorders, promote greater mental health literacy, and promote policies to support needed services," investigators write.

This new data highlights the need to address certain sociocultural, socioeconomic, and environmental factors that can more strongly affect individuals in minority groups.

The study revealed several concerning trends in the utilization of acute mental health care among youth during the second year of the COVID-19 pandemic.

Juliana Reed, MS, predicts what the future holds regarding biosimilar access in the United States.

Experts emphasize the fundamental principles of integrative care, the success seen in treating rare diseases, and how it can be applied to all chronic diseases.

Juliana Reed, MS, explains the factors decision-makers need to consider to ensure lower-cost adalimumab biosimilars reach millions of patients in the United States.

An update to guidances prioritizes practices that complete RNA testing on all HCV antibody reactive samples in one step, for the sake of complete test rates.